Form 4: Quest Diagnostics CEO Sells Shares for Tax Obligations

Quest Diagnostics CEO and President J. E. Davis disposed of 7,143 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• J. E. Davis, CEO and President of Quest Diagnostics Inc. (DGX), reported a transaction on November 5, 2025.
• The transaction involved the disposition of 7,143 shares of common stock.
• The shares were disposed of to the issuer at a price of $175.57 per share.
• This disposition was solely to cover tax withholding obligations arising from the vesting of restricted stock units.
• Following this transaction, J. E. Davis beneficially owns 120,480 shares of Quest Diagnostics common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine administrative transaction (tax withholding) and does not reflect a discretionary buy or sell decision by the insider, nor does it provide new operational or financial information about the company.

Positives

• The transaction indicates the vesting of restricted stock units, which is a form of equity compensation for the executive.
• The disposition was non-discretionary, solely to cover tax withholding, rather than a market sale by the executive.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

This is an insider transaction filing, which is specific to the individual and company, and does not directly relate to broader industry trends or competitors, other than indicating standard executive compensation practices.

Comparison to Industry Standards

• This is a standard Form 4 filing for a tax-related disposition of shares, which is a common practice for executives receiving equity compensation across various industries.

Related Party Transactions

• The transaction involves the disposition of shares to the issuer to cover tax withholding obligations, a common practice related to executive equity compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related disposition, not a discretionary sale indicating a change in confidence.

Key Dates

Recommendation

The Form 4 details a non-discretionary disposition of shares by the CEO to cover tax withholding obligations upon the vesting of restricted stock units. This is a standard administrative event and does not provide new information regarding the company's operational performance, financial health, or management's outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is maintained, pending further substantive company updates.

Keywords

Quest Diagnostics, DGX, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CEO, J. E. Davis